Study group | Control group | p-value | |
---|---|---|---|
Age (years) | 33.4 ± 2.8 | 33.2 ± 3.1 | 0.614 |
total rFSH per cycle (IU) | 696.2 ± 295.5 | 596.5 ± 304.4 | <0.001 |
Duration of stimulation (days) | 10.3 ± 2.8 | 8.4 ± 2.8 | <0.001 |
n follicles 14–17 mm | 1.4 ± 0.9 | 1.2 ± 1.2 | 0.031 |
Endometrial thickness (mm) | 9.0 ± 2.1 | 9.2 ± 3.3 | 0.554 |
Mobile sperm count (million) | 14.5 ± 12.5 | 15.6 ± 13.3 | 0.230 |
Medication expenses (€): | 452.72 ± 157.60 | 303.22 ± 132.93 | <0.001 |
Clinical pregnancy (%) | 31 (13.7 %) | 111 (16.2 %) | 0.371 |
Clinical pregnancy OR | 0.78 (0.49–1.22) | ||
Ongoing pregnancy (%): | 27 (11.9 %) | 102 (14.9 %) | 0.271 |
Ongoing pregnancy OR | 0.82 (0.53–1.26) |